Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026

High-Level Summary
The Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 aims to enhance the Australian private health system by introducing "Transparency by Default," allowing the government to publish medical fees and out-of-pocket costs to aid consumer decision-making. It also strengthens "Regulating Premiums" to prevent "product phoenixing" and increase Ministerial oversight of new and modified private health insurance product premiums, fostering greater consumer confidence and value.

Summary
The Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 (the Bill) seeks to enhance consumer confidence and informed decision-making within the private health insurance sector through two primary mechanisms:
  • Transparency by Default (Schedule 1): This measure addresses the significant issue of Australians delaying or missing specialist care due to cost, with over 800,000 people affected in 2024-25, primarily due to high medical specialist fees. Given the low uptake of voluntary participation in the Medical Costs Finder website (1-2% of specialists and 10% of insurers as of December 2025), the Bill will amend the Health Insurance Act 1973 (HI Act) and Private Health Insurance Act 2007 (PHI Act) to enable the Department of Health, Disability and Ageing to publish relevant data. This data, drawn from existing Medicare, hospital, and insurer billing records, will include information on medical practitioners' fees, qualifications, languages, locations, gap cover arrangements, healthcare facility services, and insurer-specific out-of-pocket costs. Patient privacy will be maintained, with no patient-specific information published. The department will establish an analytical method for deriving credible fee figures and an internal review process for published information. Additionally, civil immunity provisions are introduced for the Secretary of the department concerning the publication of this information.
  • Regulating Premiums (Schedule 2): This part of the Bill targets the practice known as "product phoenixing," where private health insurers close existing products and introduce new, very similar ones at higher premiums, thereby circumventing Ministerial scrutiny. This practice has contributed to substantial premium increases, such as a 58% rise in Gold hospital cover over five years for affected products, compared to an average 16% increase across all products. The amendments will require insurers to seek Ministerial approval for premiums for all new products, as well as for existing products where changes reduce cover, benefits, or other terms and conditions. This ensures consistent scrutiny of all private health insurance products against a public interest test, creating a "level playing field." The Bill also formalises the annual "Premium Round" process through legislation, providing greater certainty for both insurers and consumers. More stringent public interest tests will apply to applications submitted outside the 'approved application period' to disincentivise such submissions. The Minister will be required to table reasons for refusing premium applications before Parliament.

Argument For
Normative Bases
  1. Egalitarianism
  2. Pro-Democracy

The Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 is a crucial step towards fostering a more equitable and transparent private health insurance system in Australia. The Bill directly addresses significant financial barriers to healthcare access, which disproportionately affect vulnerable populations. Over 800,000 Australians in 2024-25 delayed or missed specialist care due to cost, with medical specialist fees identified as the primary reason. By mandating the publication of medical fees and out-of-pocket costs, the "Transparency by Default" measure will empower consumers, particularly those in lower-income and regional areas, to make informed decisions and access affordable care, thereby advancing the right to health and economic accessibility.

Furthermore, the Bill tackles the unethical practice of "product phoenixing" by private health insurers, a loophole that has allowed them to increase premiums significantly (e.g., Gold hospital cover saw a 58% increase over five years due to this practice) and reduce product value without Ministerial scrutiny. The expanded Ministerial oversight to new and modified products ensures that all premiums are subject to a public interest test, safeguarding consumers from unregulated and unfair charging behaviours. This measure also protects the Commonwealth's investment in the sustainability of the private health system, ensuring value for money for consumers who rely on private health insurance.

The overall objective of the Bill aligns with pro-democratic principles by promoting an informed and engaged citizenry in healthcare decisions. Providing clear, accessible information on medical costs and regulating premiums allows individuals to better understand their options, compare providers, and ultimately make choices that best suit their health needs and financial circumstances. This enhanced transparency and accountability within the healthcare market contribute to a more sophisticated and civil public discourse around health policy. [Judgment]


Argument Against
Normative Bases
  1. Propertarianism
  2. Value-Neutral / Epistemic Objection

While the intent to improve consumer choice and transparency is laudable, the proposed Bill introduces significant regulatory burdens on private health insurers, potentially hindering innovation and competition in the market. Insurers have expressed concerns about "reduced flexibility to open new products" and respond to market demands. The estimated annual compliance cost for the sector is $480,000, a cost that could ultimately be passed on to consumers through higher premiums or reduced benefits, contradicting the Bill's stated aims. [Judgment]

The "Regulating Premiums" schedule, while targeting "product phoenixing," may lead to unintended consequences. Insurers, under increased Ministerial scrutiny for new and modified products, might choose to protect their financial viability by other means, such as seeking higher premium increases for existing products, or reducing policy benefits and increasing excesses or co-payments. This could lead to a "minor reduction in products available within product tiers on the open market" if insurers opt to close unprofitable products rather than navigate a more stringent approval process for replacements.

Furthermore, the "Transparency by Default" measure, while aiming to inform consumers, introduces a criminal offence for unauthorised disclosure of protected information, with the onus of proof on the defendant. This raises concerns about the balance between transparency and the rights of individuals and could create a chilling effect on legitimate information sharing within the health sector, even if unintended. [Judgment] The Bill's approach, while comprehensive, might be overly prescriptive, and a less intrusive, market-based approach or more targeted regulation might achieve similar transparency and consumer protection goals with less administrative overhead and fewer potential negative impacts on product availability and insurer flexibility. [Judgment]


Date:

2026-02-12

Chamber:

House of Representatives

Status:

Before House of Representatives

Sponsor:

Unspecified

Portfolio:

Health, Disability and Ageing

Categories:

Healthcare, Consumer Protection, Financial Regulation

Timeline:
12/02/2026
25/03/2026

Comments (0)